Cariprazine, also known as Vraylar, is being studied for its potential use in various conditions, including major depressive disorder, anxiety, substance use disorders, and bipolar disorder. Research is examining its efficacy and tolerability, as well as its effects on symptoms and side effects. The medication's role and effectiveness are being evaluated in different contexts, including schizophrenia and off-label use.